These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

695 related items for PubMed ID: 16076368

  • 1. Therapeutic strategy and the role of apheresis therapy for ABO incompatible living donor liver transplantation.
    Kozaki K, Egawa H, Kasahara M, Oike F, Yoshizawa A, Fukatsu A, Tanaka K.
    Ther Apher Dial; 2005 Aug; 9(4):285-91. PubMed ID: 16076368
    [Abstract] [Full Text] [Related]

  • 2. The role of apheresis therapy for ABO incompatible living donor liver transplantation: the Kyoto University experience.
    Kozaki K, Egawa H, Ueda M, Oike F, Yoshizawa A, Fukatsu A, Takada Y.
    Ther Apher Dial; 2006 Oct; 10(5):441-8. PubMed ID: 17096700
    [Abstract] [Full Text] [Related]

  • 3. The role of plasmapheresis therapy for perioperative management in ABO-incompatible adult living donor liver transplantation.
    Ashizawa T, Matsuno N, Yokoyama T, Kihara Y, Kuzuoka K, Taira S, Konno O, Jyojima Y, Akashi I, Nakamura Y, Hama K, Iwamoto H, Iwahori T, Nagao T, Kasahara M, Tanaka K.
    Transplant Proc; 2006 Dec; 38(10):3629-32. PubMed ID: 17175351
    [Abstract] [Full Text] [Related]

  • 4. Experiences and problems pre-operative anti-CD20 monoclonal antibody infusion therapy with splenectomy and plasma exchange for ABO-incompatible living-donor liver transplantation.
    Usui M, Isaji S, Mizuno S, Sakurai H, Uemoto S.
    Clin Transplant; 2007 Dec; 21(1):24-31. PubMed ID: 17302588
    [Abstract] [Full Text] [Related]

  • 5. The role of apheresis therapy in living donor liver transplantation.
    Kozaki K, Fukatsu A, Kasahara M, Ogura Y, Egawa H, Tanaka K.
    Ther Apher Dial; 2004 Jun; 8(3):174-9. PubMed ID: 15154866
    [Abstract] [Full Text] [Related]

  • 6. New protocol of immunosuppression for liver transplantation across ABO barrier: the use of Rituximab, hepatic arterial infusion, and preservation of spleen.
    Yoshizawa A, Sakamoto S, Ogawa K, Kasahara M, Uryuhara K, Oike F, Ueda M, Takada Y, Egawa H, Tanaka K.
    Transplant Proc; 2005 May; 37(4):1718-9. PubMed ID: 15919443
    [Abstract] [Full Text] [Related]

  • 7. Adult living-donor liver transplantation with ABO-incompatible grafts.
    Testa G, Vidanovic V, Chejfec G, Gangemi A, Iqpal R, Porubsky M, Pham T, Benedetti E.
    Transplantation; 2008 Mar 15; 85(5):681-6. PubMed ID: 18337660
    [Abstract] [Full Text] [Related]

  • 8. Successful case of adult ABO-incompatible liver transplantation: beneficial effects of intrahepatic artery infusion therapy: a case report.
    Nakamura Y, Matsuno N, Iwamoto H, Yokoyama T, Kuzuoka K, Kihara Y, Taira S, Sagara T, Jojima Y, Konno O, Tashiro J, Akashi I, Hama K, Narumi K, Iwahori T, Uchiyama M, Tanaka K, Nagao T.
    Transplant Proc; 2004 Oct 15; 36(8):2269-73. PubMed ID: 15561215
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effects and problems of adult ABO-incompatible living donor liver transplantation using protocol of plasma exchange, intra-arterial infusion therapy, and anti-CD20 monoclonal antibody without splenectomy: case reports of initial experiences and results in Korea.
    Kim BW, Park YK, Kim YB, Wang HJ, Kim MW.
    Transplant Proc; 2008 Dec 15; 40(10):3772-7. PubMed ID: 19100487
    [Abstract] [Full Text] [Related]

  • 11. Rituximab, IVIG, and plasma exchange without graft local infusion treatment: a new protocol in ABO incompatible living donor liver transplantation.
    Ikegami T, Taketomi A, Soejima Y, Yoshizumi T, Uchiyama H, Harada N, Iguchi T, Hashimoto N, Maehara Y.
    Transplantation; 2009 Aug 15; 88(3):303-7. PubMed ID: 19667930
    [Abstract] [Full Text] [Related]

  • 12. B-cell surface marker analysis for improvement of rituximab prophylaxis in ABO-incompatible adult living donor liver transplantation.
    Egawa H, Ohmori K, Haga H, Tsuji H, Yurugi K, Miyagawa-Hayashino A, Oike F, Fukuda A, Yoshizawa J, Takada Y, Tanaka K, Maekawa T, Ozawa K, Uemoto S.
    Liver Transpl; 2007 Apr 15; 13(4):579-88. PubMed ID: 17394164
    [Abstract] [Full Text] [Related]

  • 13. Adult ABO-incompatible liver transplantation, using A and B donors.
    Skogsberg U, Breimer ME, Friman S, Mjörnstedt L, Mölne J, Olausson M, Rydberg L, Svalander CT, Bäckman L.
    Xenotransplantation; 2006 Mar 15; 13(2):154-9. PubMed ID: 16623811
    [Abstract] [Full Text] [Related]

  • 14. Dual living donor liver transplantation with ABO-incompatible and ABO-compatible grafts to overcome small-for-size graft and ABO blood group barrier.
    Song GW, Lee SG, Hwang S, Kim KH, Ahn CS, Moon DB, Ha TY, Kwon SW, Ko GY, Kim KW.
    Liver Transpl; 2010 Apr 15; 16(4):491-8. PubMed ID: 20222051
    [Abstract] [Full Text] [Related]

  • 15. Discrepancy of B cell frequency between periphery and spleen after rituximab treatment in ABO-incompatible liver transplantation.
    Iso Y, Sawada T, Kita J, Shiraki T, Sakuraoka Y, Kato M, Shimoda M, Kubota K.
    Hepatogastroenterology; 2013 Oct 15; 60(127):1624-6. PubMed ID: 24634932
    [Abstract] [Full Text] [Related]

  • 16. Impact of intraportal donor-specific leukocyte transfusion for adult ABO-incompatible liver transplantation.
    Oya H, Sato Y, Yamamoto S, Nakatsuka H, Kobayashi T, Watanabe T, Hara Y, Kokai H, Hatakeyama K.
    Transplant Proc; 2009 Oct 15; 41(1):222-5. PubMed ID: 19249519
    [Abstract] [Full Text] [Related]

  • 17. Long-term follow-up ABO-incompatible adult living donor liver transplantation in cirrhotic patients.
    Matsuno N, Nakamura Y, Mejit A, Hama K, Iwamoto H, Konno O, Jojima Y, Akashi I, Iwahori T, Ashizawa T, Nagao T.
    Clin Transplant; 2007 Oct 15; 21(5):638-42. PubMed ID: 17845639
    [Abstract] [Full Text] [Related]

  • 18. Management of anti-allogeneic antibody elimination by apheresis in living donor liver transplantation.
    Kawagishi N, Takeda I, Miyagi S, Satoh K, Akamatsu Y, Sekiguchi S, Fujimori K, Sato T, Satomi S.
    Ther Apher Dial; 2007 Oct 15; 11(5):319-24. PubMed ID: 17845390
    [Abstract] [Full Text] [Related]

  • 19. Splenectomy does not offer immunological benefits in ABO-incompatible liver transplantation with a preoperative rituximab.
    Raut V, Mori A, Kaido T, Ogura Y, Taku I, Nagai K, Sasaki N, Endo K, Hata T, Yagi S, Egawa H, Uemoto S.
    Transplantation; 2012 Jan 15; 93(1):99-105. PubMed ID: 22094955
    [Abstract] [Full Text] [Related]

  • 20. ABO-incompatible live donor renal transplantation using blood group A/B carbohydrate antigen immunoadsorption and anti-CD20 antibody treatment.
    Nordén G, Briggs D, Cockwell P, Lipkin G, Mjörnstedt L, Mölne J, Ready A, Rydberg L, Samuelsson O, Svalander CT, Breimer ME.
    Xenotransplantation; 2006 Mar 15; 13(2):148-53. PubMed ID: 16623810
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.